August 2017 ARTICLE LIST >>
PharmaTutor (August - 2017)
ISSN: 2347 - 7881
(Volume 5, Issue 8)
Received On: 04/04/2017; Accepted On: 24/04/2017; Published On: 01/08/2017
AUTHORS:
P.Dhaneshwar1*, P.Stephen2, A.N.Rajalakshmi1
1 Department of Pharmaceutics,
College of Pharmacy,
Mother Theresa Post Graduate & Research Institute Of Health Sciences, Puducherry, India
2Saimirrainno pharm pvt ltd,
Ambattur, Chennai, India
*dhanesh7pharma@gmail.com
ABSTRACT:
Drug absorption in the gastrointestinal tract is a highly variable process and prolonging gastric retention of the dosage form extends the time for drug absorption. Novel drug delivery system overcomes the physiological problems of short gastric retention through various approaches including floating drug delivery systems (FDDS), these systems float due to bulk density less than gastric fluids and so, remain buoyant in the stomach for a prolonged period of time, releases the drug slowly at the desired rate from the system and increase the bioavailability of narrow absorption window drugs. This review entitles the applications of sustained release effervescent floating bilayer tablets, suitable for sustained release of those drugs incompatible with floating constituents over an extended period of time for better patient compliance and acceptability. The purpose of this paper is to review the principle of sustained release effervescent floating drug delivery system, current technology used in the development of same as well as summarizes the applications, advantages, methodology, evaluation methods and future potential for sustained release effervescent floating bilayer tablets.
How to cite this article: Dhaneshwar P, Stephen P, Rajalakshmi AN;Sustained release effervescent floating bilayer tablets - A review of Novel Approach; PharmaTutor; 2017; 5(8);32-40
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Bolton S, Desai S; Floating sustained release therapeutic compositions; US Patent; 4, 814, 179; March 21; 1989.
2. Desai S.A; Novel Floating controlled release drug delivery system based on a dried gel matrix Network (master’s thesis) Jamaica; NY: St. John’s University; 1984.
3. Dixit N. Floating Drug Delivery System. J Current Pharm Res. 2011;7(1):6-20.
4. Jain N K; Progress in controlled and novel drug delivery systems, First Ed.; 2004,CBS Publishers and Distributors; New Delhi; Bangalore: 84-85.
5. Jimenez-Castellanous N.R, Zia H and Rhodes C.T; Mucoadhesive drug delivery Systems; Drug Development and Industrial Pharmacy; 1993; 19; 143.
6. Mojaverian P, Ferguson R.K, Vlasses P.H; Estimation of gastric residence time of the heidelberg capsules in humans: effect of varying food composition; Scandinavianjournal of Gastroenterology; 1985; 89; 392-397.
7. Pujar ND, Gokani RK, Paun JS. Bilayer Tablet – An Emerging Trend. International Journal of Pharmaceutical Research and Development. 2012, 4, 102 – 111.
8. Talukder R and Fissihi R; Gastroretentive delivery systems: A mini review; Drug Development & Industrial pharmacy; 2004; 30(10); 1019-1028.
9. Timmermans J, Andre J.M; Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy; Journal of Pharmaceutical science; 1994; 83; 18-24.
10. Vantrappen G.R, Peeters T.L, Janssens J; The secretory component of interdigestive migratory motor complex in man; Journal of Gastroenterology; 1979; 14;663-667.
11. Whitehead L, Fell J.T, Collett J.H; Development of a gastroretentive dosage form; European Journal of Pharmaceutical Sciences; 1996; 4(1); 182.
12. Wilson C.G, Washington N; The stomach: its role in oral drug delivery. In: physiological pharmaceutical biological barriers to drug absorption. Chichester, UK: Ellis Horwood; 1989; 47-70.
13. Xu W.L, Tu X.D, Lu Z.D; Develpoment of Gentamycin sulfate sustained release tablets remaining-floating in stomach; AAPS Pharm Tech;1991; 26(7); 541-545.
14. Yang L, Eshraghi J, Fassihi R; A new intragasrtic delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation; Journal of Controlled Release; 1989; 57;215-222.
.png)
